Developmental delay of <i>rpS13/+</i> animals is not due to a decrease in ribosome numbers or reduced translation rates. by Lisa Patricia Deliu (13570709)

RGDfV increases ceramides and decreases sphingomyelins, and these changes are abrogated following ASM. knockdown. by Xiuhai Ren (312555)

PGC-1β KO mice show a specific decrease in Mfn2 expression in skeletal muscle. by Marc Liesa (35879)

Decreased oligodendrocyte precursor number in developing white matter tracts. by Mark D. Grier (726986)

Clinical and genetic characteristics of 5 patients harboring mutations in the <i>NR5A1</i> gene. by Jana Malikova (615672)

Subjects:

Overexpression of PR decreases Myc expression and activity. by Tamar Kavlashvili (849072)

Participants characteristics. by Sakiko Fukui (387048)

Subjects:

Autophagy is decreased at later time points post-infection in human macrophages. by Grant R. Campbell (298586)

Selective downregulation of SR Ca²⁺ handling proteins and decreased SR Ca²⁺ uptake in TG mice hearts. by Mayilvahanan Shanmugam (691549)

“…<b>*</b>indicates the significant difference (p<0.05) between NTG and TG groups. n = 5. Calcium dependent SR Ca²⁺ uptake is significantly decreased in atria <b>(E)</b> and in the ventricles <b>(F)</b> of one-month old TG mice. …”

Infectivity of HIV-1 particles decreases upon treatment with MEK inhibitor. by Sheila Mansouri (324272)

PAP decreases expression of HIV-1 proteins without toxicity to cells. by Sheila Mansouri (324272)

Decreased synthesis of HIV-1 particles by PAP reduces productive infection. by Sheila Mansouri (324272)

SF pretreatment inhibited the I/R induced decrease in the IRL thickness. by Hong Pan (8686)

<i>T. cruzi</i> PCM abrogates MAP kinase activation and decreased MAP kinase signaling results in inhibition of ctgf/ccn2 expression. by G. Adam Mott (198973)

N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

“…<p>(<b>A</b>) N100 amplitude reduction during 1 Hz-rTMS (group mean values). …”

Decreases in muscle size, muscle force, and TB mass in 3-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…Representative values of at least two independent experiments. <i>Columns,</i> mean; <i>bars</i>, s.d. E) eRMS RD cells were treated during 24 hours with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”

miR-146a and miR-155 levels decrease at the convalescent stage in patients with <i>V</i>. <i>cholerae</i> O1 infection. by Aziz Bitar (257322)

Comprehensive microarray polymer profiling of powdered textile processing samples. by Jean-Luc Runavot (657205)

PF treatment decreases the mRNA expressions of TNFα (A) and IL-1β (B) in the brain. by Ruo-Bing Guo (298949)